Search

everythinglearnresearchcommunity

for

Search:↓

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Fibrosing alopecia starts earlier in Latin American men and often looks like common male pattern baldness.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

Many skin patients have mental health issues, but few dermatologists are well-versed in treating these conditions.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Hair loss in black women needs more research, early intervention, and community education.

Many skin patients also have mental health issues, and doctors should treat both together.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Dermocosmetics help manage skin issues in cancer patients, improving outcomes and reducing treatment interruptions.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

The transtemporal midface lift improves the lower eyelid and cheek area with high patient satisfaction and low complication rates.

The document concludes that the endoscopic brow lift is a less invasive cosmetic surgery that requires careful technique and patient selection to achieve lasting, aesthetically pleasing results.

The document concludes that careful planning and consideration of male brow anatomy are essential for successful facial rejuvenation with cosmetic surgery.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Psychotropic drugs can help treat skin conditions affected by mental health, but dermatologists must use them carefully due to side effects and patient concerns.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

The book details skin conditions in older adults, their link to mental health, cancer treatment importance, hair loss remedies, and managing autoimmune and itchy skin.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Cancer survivors need better skin care to improve their quality of life.

FUE hair transplants are generally safe but require careful planning to avoid rare complications.

The COVID-19 pandemic led to fewer dermatology patients, more stress-related skin conditions during the crisis, and a rise in contact dermatitis after, with ongoing concerns for public health and treatment delays.